Pharmacosmos

CompanyDenmark

Pharmacosmos develops one asset, in phase 3 (Ferric Derisomaltose in chronic heart failure). Mostly other; based in Denmark.

Assets
1
Furthest
Phase 3
Trials
5
Signals
0

Pipeline

1

  • Ferric Derisomaltose

    Iron carbohydrate complex for intravenous replenishment of iron stores

    Phase 3Otherchronic heart failureiron deficiency

Full company profiles: pipeline, trials, funding and people.

See Pro
  • Trials5
  • Similar companies6

Updated 7 Oct 2026 · 6 sources

Intelligence